Chardan Capital Forecasts Strong Price Appreciation for Hyperliquid Strategies (NASDAQ:PURR) Stock

Hyperliquid Strategies (NASDAQ:PURR) had its target price boosted by investment analysts at Chardan Capital from $8.15 to $8.45 in a research report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Chardan Capital’s price target would suggest a potential upside of 95.60% from the company’s previous close.

Hyperliquid Strategies Price Performance

NASDAQ:PURR opened at $4.32 on Thursday. Hyperliquid Strategies has a 1-year low of $3.01 and a 1-year high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last released its quarterly earnings results on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter. The company had revenue of $0.50 million during the quarter.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in PURR. GM Advisory Group LLC acquired a new position in Hyperliquid Strategies during the 4th quarter worth $2,946,000. HRT Financial LP bought a new position in shares of Hyperliquid Strategies during the fourth quarter worth about $856,000. Jane Street Group LLC acquired a new position in Hyperliquid Strategies in the fourth quarter worth about $339,000. Finally, EHP Funds Inc. bought a new stake in Hyperliquid Strategies in the fourth quarter valued at about $302,000. 9.45% of the stock is currently owned by institutional investors.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.